Hotline:
+ 49 (0) 2204 2918806

Estudios en la categoría Medicamentos/Fármacos

Artículo 1 hasta 10 de 7745

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 775
  1. Precio neto*
    Año
  2. US$ 284,11
    2015
    Für diese Studie liegt keine Bewertung vor.

    Actinogen Limited (ACW) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    Actinogen Limited (Actinogen) is a biotechnology company. The company discovers and isolates a group of environmental bacteria. It offers services such as detection of soil actinomycetes, isolation of soil actinomycetes, and screening test services. The company’s projects include plant growth hormones, shikimic acid, bio-ethanol researc
    Englisch | Zukunftsanalyse | Código: 143218
  3. € 490,00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Vitamin and Provitamin Market in Kazakhstan to 2018 - Market Size, Trends, and Forecasts

    Global Research & Data Services.
    33 Páginas
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for vitamins and provitamins in Kazakhstan. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for industry executives, marketing, sales and
    Englisch | Marktstudie | Código: 987655336
  4. US$ 1.894,08
    2012
    Für diese Studie liegt keine Bewertung vor.

    Cellulite – Pipeline Review, H2 2012

    Global Markets Direct
    41 Páginas
    Introduction Global Markets Direct’s, 'Cellulite - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cellulite, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key play
    Englisch | Report | Código: 317879
  5. US$ 468,78
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT budget forecasts in Small Finnish Insurers - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 Páginas
    SynopsisThis report illustrates how Kable expects Small Finnish Insurers to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend prediction statistical mode
    Englisch | Databook | Código: 332261
  6. US$ 284,11
    2015
    Für diese Studie liegt keine Bewertung vor.

    Medi-Flex Limited (5FF) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of Medi-Flex Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile he
    Englisch | Zukunftsanalyse | Código: 85388
  7. US$ 3.309,90
    2014
    Für diese Studie liegt keine Bewertung vor.

    Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

    GlobalData
    72 Páginas
    GlobalData has released its new PharmaPoint Drug Evaluation report, “Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare s
    Englisch | Zukunftsanalyse | Código: 987672147
  8. US$ 1.420,56
    2012
    Für diese Studie liegt keine Bewertung vor.

    Epistem Holdings Plc – Product Pipeline Review – 2012

    Global Markets Direct
    37 Páginas
    Introduction Global Market Direct’s pharmaceuticals report, “Epistem Holdings Plc - Product Pipeline Review - 2012” provides data on the Epistem Holdings Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant pr
    Englisch | Report | Código: 318519
  9. US$ 1.420,56
    2013
    Für diese Studie liegt keine Bewertung vor.

    Siena Biotech S.p.A. - Product Pipeline Review - 2013

    Global Markets Direct
    37 Páginas
    Global Market Direct’s pharmaceuticals report, “Siena Biotech S.p.A. - Product Pipeline Review - 2013” provides data on the Siena Biotech S.p.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This
    Englisch | Zukunftsanalyse | Código: 386327
  10. US$ 284,11
    2015
    Für diese Studie liegt keine Bewertung vor.

    CSI Co., Ltd. (4320) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Páginas
    CSI Co., Ltd. (CSI) is a healthcare information technology company. The company develops solutions for the medical institutions. It provides medical system development and contract system development business. CSI offers products and solutions such as electronic medical record system, regional medical cooperation network service ID-link,
    Englisch | Zukunftsanalyse | Código: 350369
  11. US$ 1.420,56
    2015
    Für diese Studie liegt keine Bewertung vor.

    Axxam SpA - Product Pipeline Review - 2015

    Global Markets Direct
    20 Páginas
    Global Markets Direct’s, ‘Axxam SpA - Product Pipeline Review - 2015’, provides an overview of the Axxam SpA’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Axxam SpA’s, complete with comparative analysis at various stages, therap
    Englisch | Zukunftsanalyse | Código: 987680204

Artículo 1 hasta 10 de 7745

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 775